Stockscreener 앱 받기
1.02
0.97%
-0.01
시간 외 거래:
1.04
0.02
+1.96%
전일 마감가:
$1.03
열려 있는:
$1.04
하루 거래량:
624.98K
Relative Volume:
0.84
시가총액:
$199.16M
수익:
$4.71M
순이익/손실:
$-58.01M
주가수익비율:
-1.2388
EPS:
-0.8234
순현금흐름:
$-46.68M
1주 성능:
-6.42%
1개월 성능:
-11.30%
6개월 성능:
-1.92%
1년 성능:
-9.73%
1일 변동 폭
$1.02
$1.06
1주일 범위
$1.02
$1.1198
52주 변동 폭
$0.9495
$1.70
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.02 | 201.11M | 4.71M | -58.01M | -46.68M | -0.8234 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
Lucid Diagnostics Inc. (LUCD) may report negative earnings: Know the trend ahead of next week's release - MSN
Lucid Diagnostics Stock Price Forecast. Should You Buy LUCD? - StockInvest.us
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Lucid Diagnostics Inc. (LUCD) reports Q4 loss, beats revenue estimates - MSN
PAVmed will outline Q1 results and strategy in a May 15 webcast - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) seeks big share increase in 2026 proxy - Stock Titan
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - BioSpace
Lucid Diagnostics will detail Q1 results and strategy on May 14 - Stock Titan
Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG - MSN
Lucid Diagnostics closes underwritten offering of common stock - Medical Buyer
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - marketscreener.com
Lucid Diagnostics Raises Capital Through Direct Share Offering - The Globe and Mail
Lucid Diagnostics closes $18M stock offering at $1 per share - Investing.com Australia
Lucid Diagnostics (LUCD) CMO reports 650K restricted shares and 100K options - Stock Titan
Lucid Diagnostics closes $18M underwritten offering, issues 18M shares at $1.00 - TradingView
Lucid Diagnostics (NASDAQ: LUCD) closes $18M underwritten stock sale - Stock Titan
Lucid Diagnostics Closes $18 Million Share Offering - Intellectia AI
Lucid Diagnostics prices $18M stock offering at $1 per share - Investing.com India
Lucid Diagnostics Prices $18 Million Public Equity Offering - TipRanks
Lucid Diagnostics (LUCD) raises $18M with 18M-share offering (NASDAQ: LUCD) - Stock Titan
Lucid Diagnostics Prices $18 Million Underwritten Offering at $1 Per Share With Canaccord and BTIG - TradingView
Lucid Diagnostics (Nasdaq: LUCD) prices $18M underwritten stock sale - Stock Titan
Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering - TipRanks
Lucid Diagnostics prices $18M stock offering at $1 per share By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - PR Newswire
Lucid Diagnostics (LUCD) Annual Recap | Lucid Diagnostics posts 2% EPS beat, beats consensus loss estimatesDividend Cut Risk - Xã Vĩnh Công
Lucid Diagnostics (NASDAQ: LUCD) seeks 100M-share authorization increase - Stock Titan
Lucid Diagnostics (LUCD) Stock: Why It Matters Now (+3.20%) 2026-04-20Risk Management - Xã Vĩnh Công
Needham Reiterates Lucid Diagnostics (LUCD) Buy Recommendation - MSN
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Needham Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Victoria Tou Ho Lee Net Worth (2026) - GuruFocus
Lucid Diagnostics Outperforms Pressure BioSciences in Key Metrics - National Today
Lucid Diagnostics (LUCD) CMO holds 650K shares including restricted stock - Stock Titan
Layoff Watch: Whats the MACD signal for Lucid Diagnostics Inc2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - Quantisnow
Fed Meeting: Is Lucid Diagnostics Inc stock forming a cup and handle2026 PreEarnings & Community Consensus Picks - baoquankhu1.vn
Dividend Watch: Can Lucid Diagnostics Inc be recession proofTrade Exit Report & Precise Swing Trade Alerts - baoquankhu1.vn
Ascendiant Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Raises Target Price to $9 - Moomoo
Breakout Move: What is the next catalyst for Lucid Diagnostics Inc2026 Performance Recap & Daily Profit Maximizing Tips - baoquankhu1.vn
Lucid Diagnostics to Participate in Needham Healthcare Conference - National Today
Lucid Diagnostics to Participate in Fireside Chat at the 25th An - GuruFocus
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - Bitget
Lucid Diagnostics to Participate in Fireside Chat at Healthcare Conference - National Today
Lucid Diagnostics CEO to Participate in Healthcare Conference - Intellectia AI
Lucid Diagnostics Inc. $LUCD Shares Purchased by Aberdeen Group plc - MarketBeat
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):